Rapamycin Is Highly Effective in a Mouse Model of Immune-Mediated Bone Marrow Failure By Mechanisms Distinct from Cyclosporine

被引：0
|
作者：
Feng, Xingmin [1 ]
Lin, Zenghua [1 ]
Desierto, Marie [1 ]
Keyvanfar, Keyvan [1 ]
Malide, Daniela [2 ]
Chen, Jichun [1 ]
Young, Neal S. [1 ]
机构：
[1] NHLBI, Hematol Branch, NIH, Bethesda, MD 20892 USA
[2] NHLBI, Light Microscopy Core Facil, NIH, Bethesda, MD 20892 USA
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] The effectiveness of a novel treatment of TIM-3(-) NK cells infusion in murine models of immune-mediated bone marrow failure
    Ding, Shaoxue
    Zhang, Tian
    Liu, Zixuan
    Cui, Yi
    Liu, Chunyan
    Fu, Rong
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2023, 37 (13-14)
  • [42] Increased Expression of TIGIT on CD4+ T Cells Ameliorates Immune-Mediated Bone Marrow Failure of Aplastic Anemia
    Zhang, Tao
    Wang, Jianhong
    Zhou, Xingchun
    Liang, Rong
    Bai, Qingxian
    Yang, Lan
    Gu, Hongtao
    Gao, Guangxun
    Dong, Baoxia
    Zhu, Huafeng
    Chen, Xiequn
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2014, 115 (11) : 1918 - 1927
  • [43] Lymphocytes with Aberrant Expression of Fas or Fas Ligand Attenuate Immune Bone Marrow Failure in a Mouse Model
    Omokaro, Stephanie O.
    Desierto, Marie J.
    Eckhaus, Michael A.
    Ellison, Felicia M.
    Chen, Jichun
    Young, Neal S.
    JOURNAL OF IMMUNOLOGY, 2009, 182 (06): : 3414 - 3422
  • [44] Minimal role of interleukin 6 and toll-like receptor 2 and 4 in murine models of immune-mediated bone marrow failure
    Solorzano, Sabrina
    Kim, Jisoo
    Chen, Jichun
    Feng, Xingmin
    Young, Neal S.
    PLOS ONE, 2021, 16 (03):
  • [45] Long-term follow up of patients with immune-mediated Bone Marrow Failure Syndromes treated with Alemtuzumab-based immunosuppression
    Pagliuca, S.
    Marotta, S.
    Grimaldi, F.
    Ricci, P.
    Luciano, L.
    Risitano, A.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S494 - S494
  • [46] ULBP and MICA/B as novel indicators for both diagnosis of immune-mediated marrow injury and favorable response to immumosuppressive therapy in bone marrow failure syndromes.
    Hanaoka, Nobuyoshi
    Kawaguchi, Tatsuya
    Horikawa, Kentaro
    Nagakura, Shoichi
    Tsuzuki, Yasuchika
    Yonemura, Yuji
    Nakakuma, Hideki
    BLOOD, 2006, 108 (11) : 295A - 296A
  • [47] GENERATION OF CFU-C-SUPPRESSOR T-CELLS INVITRO - AN EXPERIMENTAL-MODEL FOR IMMUNE-MEDIATED MARROW FAILURE
    BACIGALUPO, A
    PODESTA, M
    MINGARI, MC
    MORETTA, L
    PIAGGIO, G
    VANLINT, MT
    DURANDO, A
    MARMONT, AM
    BLOOD, 1981, 57 (03) : 491 - 496
  • [48] Subcutaneous alemtuzumab is safe and effective for treatment of global or single-lineage immune-mediated marrow failure: a pilot study from the working party aplastic anaemia (WPSAA)
    Risitano, A.
    Marando, L.
    Selleri, C.
    Serio, B.
    Seneca, E.
    Camera, A.
    Catalano, L.
    Scalia, G.
    Del Vecchio, L.
    Iori, A.
    Maury, S.
    Bacigalupo, A.
    Socie, G.
    Tichelli, A.
    Marsh, J.
    Schrezenmeier, H.
    Passweg, J.
    Rotoli, B.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S19 - S19
  • [49] Tumor Necrosis Factor-α in Target Cells but Not in Effector Cells Plays Critical Roles in Development of Murine Immune-Mediated Bone Marrow Failure
    Feng, Xingmin
    Sun, Wanling
    Wu, Zhijie
    Lin, Zenghua
    Hollinger, Maile K.
    Chen, Jichun
    Young, Neal S.
    BLOOD, 2017, 130
  • [50] HYPOMEGAKARYOCYTIC THROMBOCYTOPENIA (HMT): AN IMMUNE-MEDIATED BONE MARROW FAILURE CHARACTERIZED BY AN INCREASED NUMBER OF PNH-PHENOTYPE CELLS AND PLASMA THROMBOPOIETIN LEVELS
    Ishiyama, K.
    Yamazaki, H.
    Saito, C.
    Zaimoku, Y.
    Maruyama, H.
    Nakao, S.
    HAEMATOLOGICA, 2015, 100 : 243 - 244
12345